Jpmorgan Chase & CO Regeneron Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,489,500 shares of REGN stock, worth $5.57 Billion. This represents 0.65% of its overall portfolio holdings.

Number of Shares

7,489,500

Previous 8,277,315 9.52%

Holding current value

$5.57 Billion

Previous $8.7 Billion 9.5%

% of portfolio

0.65%

Previous 0.77%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $807 Million - $947 Million	-787,815 Reduced 9.52%	7,489,500 $7.87 Billion
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $486 Million - $589 Million	550,141 Added 7.12%	8,277,315 $8.7 Billion
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $452 Million - $497 Million	500,405 Added 6.92%	7,727,174 $7.44 Billion
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $126 Million - $143 Million	-162,385 Reduced 2.2%	7,226,769 $6.35 Billion
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $585 Million - $714 Million	845,167 Added 12.92%	7,389,154 $6.08 Billion
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $140 Million - $166 Million	199,836 Added 3.15%	6,543,987 $4.7 Billion
Q1 2023 May 18, 2023	BUY	$680.49 - $826.97 $34.4 Million - $41.8 Million	50,600 Added 0.8%	6,344,151 $5.21 Billion
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $125 Million - $152 Million	184,006 Added 3.01%	6,293,551 $5.17 Billion
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $285 Million - $309 Million	403,676 Added 7.07%	6,109,545 $4.41 Billion
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $15.7 Million - $19.9 Million	27,437 Added 0.48%	5,705,869 $3.93 Billion
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $391 Million - $527 Million	713,465 Added 14.37%	5,678,432 $3.36 Billion
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $222 Million - $261 Million	373,438 Added 8.13%	4,964,967 $3.47 Billion
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $266 Million - $328 Million	489,084 Added 11.92%	4,591,529 $2.9 Billion
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $2.35 Billion - $2.79 Billion	4,102,445 New	4,102,445 $2.48 Billion

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Regeneron Pharmaceuticals, Inc. Transaction History